Objectives: To evaluate SHP465 mixed amphetamine salts (MAS) extended-release efficacy, safety, and tolerability by age group in children and adolescents with attention-deficit/hyperactiv...
Background: Executive function (EF) deficits are not generally considered synonymous with attention-deficit/hyperactivity disorder (ADHD). Evidence suggests stimulants improve ADHD sympto...
Adult attention-deficit/hyperactivity disorder (ADHD) is associated with impaired executive function (EF). This post hoc analysis examines relationships between changes in ADHD symptoms a...
In adults with attention-deficit/hyperactivity disorder (ADHD), reductions in ADHD-Rating Scale-IV total score (ADHD-RS-IV-TS) were significantly greater with SHP465 mixed amphetamine sal...
Background: Children and adolescents with attention-deficit/hyperactivity disorder (ADHD) face significant disease burden. We evaluated disease burden in children/adolescents with ADHD an...
Background: Adolescents diagnosed with attention-deficit/hyperactivity disorder (ADHD) face significant disease burden. This cross-sectional survey evaluated ADHD burden from the perspect...